<DOC>
	<DOCNO>NCT01864109</DOCNO>
	<brief_summary>The purpose study find effect , good and/or bad , combination irinotecan temozolomide Ewing sarcoma . Irinotecan temozolomide chemotherapy drug use often treat pediatric patient MSKCC . The investigator use two drug many year treat patient Ewing sarcoma whose cancer relapse . For patient newly diagnose Ewing sarcoma current standard care MSKCC five drug chemotherapy regimen combination surgery and/or radiation therapy . This standard regimen call EFT regimen . . Some patient Ewing sarcoma cancer cure chemotherapy surgery/radiation therapy . This study add chemotherapy drug call irinotecan temozolomide standard EFT regimen . The investigator try improve success standard therapy add drug . The use irinotecan temozolomide study experimental use patient newly diagnose Ewing sarcoma . However investigator find drug effective patient relapse Ewing sarcoma . It known add two drug improve outcome patient treat Ewing sarcoma .</brief_summary>
	<brief_title>Irinotecan Temozolomide Combination With Existing High Dose Alkylator Based Chemotherapy Treatment Patients With Newly Diagnosed Ewing Sarcoma</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Alkylating Agents</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Age great equal one year less equal 40 year time diagnosis Newly diagnose , previously untreated patient histologically molecularly confirm Ewing sarcoma Adequate hematologic function : Absolute neutrophil count ≥ 1,000/μL Platelet count ≥ 100,000/μL Adequate renal function : Normal creatinine age ( See table ) OR Creatinine clearance radioisotope GFR ≥ 70ml/min/1.73 m2 Age ( Years ) Maximum Serum Creatinine ( mg/dL ) ≤ 5 0.8 6 ≤ 10 1 11 ≤ 15 1.2 ≥ 16 1.5 Adequate hepatic function : Total bilirubin ≤ 1.5 x ULN AST ≤ 2.5 x ULN [ absence hepatic involvement tumor ] ALT ≤ 2.5 x ULN [ absence hepatic involvement tumor ] Normal cardiac function : Shortening fraction great equal 28 % echocardiogram OR Left ventricular ejection fraction ( LVEF ) great equal 50 % technetium 99m pertechnetate radionuclide cineangiography ( MUGA ) echocardiogram Patients must consent indwell central venous catheter . Sexually active patient reproductive potential must willing use effective method contraception . Prior chemotherapy radiotherapy ( limited , emergent radiotherapy treatment eg . spinal cord compromise threaten airway ) Pregnant breastfeeding female</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>CYCLOPHOSPHAMIDE ( CYTOXAN )</keyword>
	<keyword>DOXORUBICIN/ADRIAMYCIN</keyword>
	<keyword>ETOPOSIDE ( VP-16 )</keyword>
	<keyword>IFOSFAMIDE</keyword>
	<keyword>IRINOTECAN ( CPT-11 ) CAMPTOSAR</keyword>
	<keyword>TEMOZOLOMIDE</keyword>
	<keyword>VINCRISTINE</keyword>
	<keyword>13-068</keyword>
</DOC>